John Yung
Stock Analyst at Citi
(2.19)
# 3,228
Out of 5,125 analysts
26
Total ratings
34.6%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by John Yung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Buy | $11.50 → $14.00 | $8.44 | +65.88% | 5 | Aug 21, 2026 | |
| HKG: 2196 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Reiterated: Buy | $35.30 | $16.74 | n/a | 2 | Oct 29, 2025 | |
| HKG: 2005 SSY Group Limited | Reiterated: Buy | $7.00 → $5.00 | $2.64 | n/a | 2 | Sep 5, 2025 | |
| HKG: 2273 Gushengtang Holdings Limited | Reiterated: Buy | $55.00 | $29.64 | n/a | 3 | Sep 1, 2025 | |
| HKG: 1513 Livzon Pharmaceutical Group Inc. | Reiterated: Buy | $48.00 | $24.40 | n/a | 1 | Aug 26, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $35.00 → $40.00 | $48.28 | n/a | 2 | Aug 21, 2025 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Reiterated: Buy | $41.00 → $70.00 | $70.55 | n/a | 2 | Aug 20, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Reiterated: Buy | $32.00 → $45.00 | $34.22 | n/a | 2 | Aug 20, 2025 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Reiterated: Buy | $8.80 → $10.80 | $5.48 | n/a | 2 | Aug 19, 2025 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Reiterated: Buy | $8.50 | $3.01 | n/a | 1 | Jul 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74.00 | $191.70 | n/a | 1 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 → $38.90 | $23.74 | n/a | 2 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62.00 | $85.90 | n/a | 1 | Nov 10, 2023 |
CSPC Pharmaceutical Group Limited
Aug 21, 2026
Reiterated: Buy
Price Target: $11.50 → $14.00
Current: $8.44
Upside: +65.88%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Oct 29, 2025
Reiterated: Buy
Price Target: $35.30
Current: $16.74
Upside: n/a
SSY Group Limited
Sep 5, 2025
Reiterated: Buy
Price Target: $7.00 → $5.00
Current: $2.64
Upside: n/a
Gushengtang Holdings Limited
Sep 1, 2025
Reiterated: Buy
Price Target: $55.00
Current: $29.64
Upside: n/a
Livzon Pharmaceutical Group Inc.
Aug 26, 2025
Reiterated: Buy
Price Target: $48.00
Current: $24.40
Upside: n/a
WuXi Biologics (Cayman) Inc.
Aug 21, 2025
Reiterated: Buy
Price Target: $35.00 → $40.00
Current: $48.28
Upside: n/a
WuXi XDC Cayman Inc.
Aug 20, 2025
Reiterated: Buy
Price Target: $41.00 → $70.00
Current: $70.55
Upside: n/a
Hansoh Pharmaceutical Group Company Limited
Aug 20, 2025
Reiterated: Buy
Price Target: $32.00 → $45.00
Current: $34.22
Upside: n/a
Sino Biopharmaceutical Limited
Aug 19, 2025
Reiterated: Buy
Price Target: $8.80 → $10.80
Current: $5.48
Upside: n/a
Alibaba Health Information Technology Limited
Jul 4, 2025
Reiterated: Buy
Price Target: $8.50
Current: $3.01
Upside: n/a
Dec 27, 2024
Reiterated: Buy
Price Target: $74.00
Current: $191.70
Upside: n/a
Aug 30, 2024
Reiterated: Buy
Price Target: $40.00 → $38.90
Current: $23.74
Upside: n/a
Nov 10, 2023
Reiterated: Buy
Price Target: $62.00
Current: $85.90
Upside: n/a